Tadomon 250 mg tablete s produljenim oslobađanjem
Name | Tadomon 250 mg tablete s produljenim oslobađanjem |
---|---|
Former Name | Tapentadol Laboratorios Liconsa 250 mg tablete s produljenim oslobađanjem |
Marketing Authorisation Number | HR-H-239998607 |
Active Substance | tapentadoltartarat |
Composition | jedna tableta s produljenim oslobađanjem sadrži 250 mg tapentadola (u obliku tapentadoltartarata) |
Pharmaceutical Form | Tableta s produljenim oslobađanjem |
Manufacturer | Laboratorios Liconsa S.A., Azuqueca de Henares, Guadalajara, Španjolska G.L. Pharma GmbH, Lannach, Austrija |
Marketing Authorisation Holder | G.L. Pharma GmbH, Schlossplatz 1, Lannach, Austrija |
Marketing Authorisation Date | 22.03.2024 |
MA Period of Validity | 07.07.2027 |
Classification Number | UP/I-530-09/21-01/71 |
Registration Number | 381-12-01/70-24-11 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | poseban recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | N02AX06 |
SmPC | download |
PL | download |
Public Assessment Report | download |